Psilera is a leading biotechnology research company that is revolutionizing the field of psychedelic therapies. With a focus on developing non-hallucinogenic psychedelic treatments, Psilera aims to unlock the therapeutic potential of these substances for a wide range of conditions. Through a unique combination of human insights and advanced computational screening, Psilera maximizes the therapeutic benefits of their compounds at the atomic level.

At Psilera, they are committed to staying at the forefront of biotechnological advancements. The company regularly participates in prestigious events like the Neuropsychiatric Drug Development Summit and hosts informative seminars, such as the upcoming one at the University of Michigan, where Dr. Jackie von Salm will share her expertise in drug discovery fueled by natural products.

With their dedication to innovation and cutting-edge research, Psilera is ushering in a new era of psychedelics, offering hope for improved mental health and well-being. Stay connected with Psilera for the latest updates and discoveries in this exciting field